Evidence map›Paper›PMID 36172750›Full record

ArticleTechnology in cancer research & treatment

A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol.

Anukriti Sharma, Ken B Johnson, Bihua Bie, Emily E Rhoades, Alper Sen, Yuri Kida, Jennifer Hockings, Alycia Gatta, Jacqueline Davenport, Connie Arcangelini and 9 more

Open access · goldAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Neurotrophin-3 (NT-3) as a Potential Biomarker of the Peripheral Nervous System Damage Following Breast Cancer Treatment.Pathophysiology : the official journal of the International Society for Pathophysiology · 2023
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Anukriti SharmaDepartment of Quantitative Health Sciences, 22516Lerner Research Institute, Cleveland Clinic, OH, USA.
Ken B JohnsonDepartment of Anesthesiology, 14434University of Utah, UT, USA.
Bihua BieDepartment of Anesthesiology, 2569Cleveland Clinic, OH, USA.
Emily E Rhoades170292Taussig Cancer Institute, Cleveland Clinic, OH, USA.
Alper SenDepartment of Anesthesiology, 14434University of Utah, UT, USA.
Yuri KidaDepartment of Anesthesiology, 14434University of Utah, UT, USA.
Jennifer HockingsGenomic Medicine Institute, Lerner Research Institute, 196246Cleveland Clinic, OH, USA.
Alycia Gatta170292Taussig Cancer Institute, Cleveland Clinic, OH, USA.
Jacqueline Davenport170292Taussig Cancer Institute, Cleveland Clinic, OH, USA.
Connie Arcangelini170292Taussig Cancer Institute, Cleveland Clinic, OH, USA.
Jennifer Ritzu170292Taussig Cancer Institute, Cleveland Clinic, OH, USA.
Jennifer DeVecchioGenomic Medicine Institute, Lerner Research Institute, 196246Cleveland Clinic, OH, USA.
Ron HughenDepartment of Anesthesiology, 14434University of Utah, UT, USA.
Mei Wei20270Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
G Thomas Budd170292Taussig Cancer Institute, Cleveland Clinic, OH, USA.
N Lynn Henry67159University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.ORCID 0000-0002-4771-5930
Charis Eng170292Taussig Cancer Institute, Cleveland Clinic, OH, USA.
Joseph FossDepartment of Anesthesiology, 2569Cleveland Clinic, OH, USA.
Daniel M RotroffDepartment of Quantitative Health Sciences, 22516Lerner Research Institute, Cleveland Clinic, OH, USA.ORCID 0000-0003-0553-3220
Cleveland Clinic · USUniversity of Utah · USCleveland Clinic Lerner College of Medicine · USUniversity of Michigan · US

Funding

Multi-Omic Biomarkers for Neuropathic Pain Secondary to ChemotherapyR61NS113258 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI FOSS, JOSEPH F, JOHNSON, KENWARD B · 2020 to 2020
$4.8M
Multi-Omic Biomarkers for Neuropathic Pain Secondary to ChemotherapyR33NS113258 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI FOSS, JOSEPH F, JOHNSON, KENWARD B · 2023 to 2024
$2.6M
NINDS NIH HHS R33 NS113258NINDS NIH HHS R61 NS113258
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsBreast NeoplasmsPeripheral Nervous System DiseasesTaxoidsBiomarkersBridged-Ring CompoundsCytokinesFemaleHumansMicroRNAsMulticenter Studies as TopicObservational Studies as TopicQuality of LifeRNA, MessengerAntineoplastic AgentsBiomarkersBridged-Ring CompoundsCytokinesMicroRNAsRNA, MessengertaxaneTaxoidschemotherapy-induced peripheral neuropathymetabolitesmiRNAmRNAmulti-omics

Identifiers

PMID36172750
PMCPMC9523841
OpenAlexW4298088673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.